Menu
Not yet recruiting NCT06965634

Investigation of the Effectiveness of Lung Ultrasonography in Intraoperative Fluid Management

Observational Intraoperative Fluid Management

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Lung ultrasound.
Who it may be relevant to
Registry conditions: Intraoperative Fluid Management. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of the Effectiveness of Lung Ultrasonography in the Management of Intraoperative Fluid Therapy, Prospective Observational Study

Overview

Adequate and balanced fluid resuscitation is one of the cornerstones of intraoperative patient management. Over-resuscitation leading to positive fluid balance is associated with increased postoperative mortality and morbidity. Invasive and non-invasive technologies can be used for the adequacy of intraoperative fluid therapy. Lung ultrasonography (LUS) is a safe and accurate bedside imaging method. LUS, which is frequently used in the diagnosis of postoperative hypoxemia, has also begun to be preferred for fluid management in intensive care units.

Detailed description

In this study, we aimed to investigate the effectiveness of intraoperative LUS data in the control of fluid therapy.

Interventions

  • Device Lung ultrasound
    Lung ultrasonography ; lung ultrasonography will be applied in 4 quadrants according to the LUS protocol and LUS score will be created.

Primary outcome measures

  • LUS [Time frame: peroperative]
Secondary outcome measures (9)
  • PVI [Time frame: peroperative]
  • CVP [Time frame: peroperative]
  • postoperative pulmonary complication [Time frame: postoperative 6th hour]
  • biochemical data 1 [Time frame: postoperative 6th hour]
  • biochemical data 2 [Time frame: postoperative 6th hour]
  • biochemical data 3 [Time frame: postoperative 6th hour]
  • Mechanical ventilation data 1 [Time frame: peroperative]
  • Mechanical ventilation data 2 [Time frame: peroperative]
  • Mechanical ventilation data 3 [Time frame: peroperative]

Eligibility criteria

Inclusion criteria

  • Patients with surgery with laparotomy

Exclusion criteria

  • Chronic obstructive pulmonary disease
  • Passed lung operation
  • Uncontrolled hypertension
  • Acute or chronic kidney failure

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06965634 · BursaYIEAH-2021-6-10

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗